{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:47:59Z","timestamp":1772844479236,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["CSUZC202236"],"award-info":[{"award-number":["CSUZC202236"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170510"],"award-info":[{"award-number":["32170510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2021ZK4154"],"award-info":[{"award-number":["2021ZK4154"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.toxicon.2025.108540","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T05:41:29Z","timestamp":1755236489000},"page":"108540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-Toxoplasma gondii studies of the venom peptide XYP4 from the Lycosa coelestis"],"prefix":"10.1016","volume":"266","author":[{"given":"Dongqian","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2025.108540_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2020.10.003","article-title":"Toxoplasmosis in pregnancy","volume":"255","author":"Ahmed","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.toxicon.2025.108540_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","article-title":"'Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: a Systematic Review'","volume":"17","author":"Ben-Harari","year":"2017","journal-title":"Drugs R&D"},{"key":"10.1016\/j.toxicon.2025.108540_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev-micro-091014-104100","article-title":"Lytic cycle of Toxoplasma gondii: 15 years later","volume":"69","author":"Blader","year":"2015","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.toxicon.2025.108540_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxicon.2016.05.010","article-title":"Anti-parasitic effect on Toxoplasma gondii induced by BnSP-7, a Lys49-phospholipase A2 homologue from Bothrops pauloensis venom","volume":"119","author":"Borges","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108540_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijbiomac.2014.11.035","article-title":"Insights into anti-parasitism induced by a C-type lectin from Bothrops pauloensis venom on Toxoplasma gondii","volume":"74","author":"Castanheira","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.toxicon.2025.108540_bib6","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1038\/s41467-022-32225-z","article-title":"IFN-gamma stimulated murine and human neurons mount anti-parasitic defenses against the intracellular parasite Toxoplasma gondii","volume":"13","author":"Chandrasekaran","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2025.108540_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.febslet.2004.07.019","article-title":"'Isolation and characterization of Psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei'","volume":"572","author":"Choi","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2025.108540_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-116-1-33","article-title":"Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California collaborative treatment group","volume":"116","author":"Dannemann","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.toxicon.2025.108540_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.706618","article-title":"'Tityus serrulatus (Scorpion): from the Crude Venom to the Construction of Synthetic Peptides and Their Possible Therapeutic Application Against Toxoplasma gondii Infection'","volume":"11","author":"de Assis","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.toxicon.2025.108540_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/md14040066","article-title":"In vitro effect of the synthetic cal14.1a conotoxin, derived from Conus californicus, on the human parasite Toxoplasma gondii","volume":"14","author":"De Leon-Nava","year":"2016","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.toxicon.2025.108540_bib11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/eji.201141550","article-title":"A clinical perspective of IL-1beta as the gatekeeper of inflammation","volume":"41","author":"Dinarello","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.toxicon.2025.108540_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.toxicon.2025.108540_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.toxicon.2016.09.019","article-title":"'Evaluation of antimicrobial, cytotoxic, and hemolytic activities from venom of the spider Lasiodora sp'","volume":"122","author":"Ferreira","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108540_bib14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3389\/fpsyt.2019.01012","article-title":"Negative effects of latent toxoplasmosis on mental health","volume":"10","author":"Flegr","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.toxicon.2025.108540_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14060370","article-title":"Mass-spectrometry-based lipidome and proteome profiling of Hottentotta saulcyi (Scorpiones: Buthidae) venom","volume":"14","author":"Ghezellou","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108540_bib16","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/emboj\/20.12.3132","article-title":"'Toxoplasma evacuoles: a two-step process of secretion and fusion forms the parasitophorous vacuole'","volume":"20","author":"Hakansson","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.toxicon.2025.108540_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxicon.2019.05.003","article-title":"'Anti-Toxoplasma gondii effect of two spider venoms in vitro and in vivo'","volume":"166","author":"Hou","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108540_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-3024.1998.00152.x","article-title":"A protective role for IL-6 during early infection with Toxoplasma gondii","volume":"20","author":"Jebbari","year":"1998","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.toxicon.2025.108540_bib19","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1021\/acs.molpharmaceut.8b00605","article-title":"The roles of fatty-acid modification in the activity of the anticancer peptide R-Lycosin-I","volume":"15","author":"Jian","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.toxicon.2025.108540_bib20","article-title":"'Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides'","volume":"27","author":"Li","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.toxicon.2025.108540_bib21","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1097\/CM9.0000000000002498","article-title":"Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial","volume":"135","author":"Li","year":"2022","journal-title":"Chin. Med. J. (Peking)"},{"key":"10.1016\/j.toxicon.2025.108540_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02027-17","article-title":"Evasion of human neutrophil-mediated host defense during Toxoplasma gondii infection","volume":"9","author":"Lima","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.toxicon.2025.108540_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15080477","article-title":"'Anti-Toxoplasma gondii Effects of Lipopeptide Derivatives of Lycosin-I'","volume":"15","author":"Liu","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108540_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9080934","article-title":"'Anti-Toxoplasma gondii Effects of a Novel Spider Peptide XYP1 In Vitro and In Vivo'","volume":"9","author":"Liu","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.toxicon.2025.108540_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biom8020018","article-title":"Biophysical investigations elucidating the mechanisms of action of antimicrobial peptides and their synergism","volume":"8","author":"Marquette","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.toxicon.2025.108540_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00184-5","article-title":"Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance","volume":"108","author":"McFadden","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.toxicon.2025.108540_bib27","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/AAC.01203-07","article-title":"In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone","volume":"52","author":"Meneceur","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.toxicon.2025.108540_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pt.2014.12.002","article-title":"Toxoplasma secretory granules: one population or more?","volume":"31","author":"Mercier","year":"2015","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.toxicon.2025.108540_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.17772\/gp\/61990","article-title":"'Ocular manifestation of congenital toxoplasmosis, clinical implication - case report'","volume":"87","author":"Modrzejewska","year":"2016","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.toxicon.2025.108540_bib30","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00436-018-6027-z","article-title":"'Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review'","volume":"117","author":"Montazeri","year":"2018","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.toxicon.2025.108540_bib31","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3389\/fmicb.2018.02587","article-title":"Drug resistance in Toxoplasma gondii","volume":"9","author":"Montazeri","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.toxicon.2025.108540_bib32","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"'Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis'","volume":"39","author":"Pappas","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.toxicon.2025.108540_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02021-19","article-title":"Cathelicidin peptides restrict bacterial growth via membrane perturbation and induction of reactive oxygen species","volume":"10","author":"Rowe-Magnus","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.toxicon.2025.108540_bib34","article-title":"The identification of a novel spider toxin peptide, Lycotoxin-Pa2a, with antibacterial and anti-inflammatory activities","volume":"12","author":"Shin","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.toxicon.2025.108540_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1094717","article-title":"Intracellular parasite invasion strategies","volume":"304","author":"Sibley","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.toxicon.2025.108540_bib36","doi-asserted-by":"crossref","first-page":"8413","DOI":"10.1073\/pnas.93.16.8413","article-title":"'Toxoplasma invasion: the parasitophorous vacuole is formed from host cell plasma membrane and pinches off via a fission pore'","volume":"93","author":"Suss-Toby","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxicon.2025.108540_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.peptides.2011.07.027","article-title":"Parasiticidal activity of Haemaphysalis longicornis longicin P4 peptide against Toxoplasma gondii","volume":"34","author":"Tanaka","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.toxicon.2025.108540_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.exppara.2019.01.009","article-title":"'Anti-parasitic effect on Toxoplasma gondii induced by a spider peptide lycosin-I'","volume":"198","author":"Tang","year":"2019","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.toxicon.2025.108540_bib39","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.chom.2022.10.001","article-title":"The Toxoplasma effector GRA28 promotes parasite dissemination by inducing dendritic cell-like migratory properties in infected macrophages","volume":"30","author":"Ten Hoeve","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.toxicon.2025.108540_bib40","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.3390\/toxins5122488","article-title":"A proteomics and transcriptomics investigation of the venom from the barychelid spider Trittame loki (brush-foot trapdoor)","volume":"5","author":"Undheim","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108540_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2019.183107","article-title":"'Aggregation determines the selectivity of membrane-active anticancer and antimicrobial peptides: the case of killerFLIP'","volume":"1862","author":"Vaezi","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.toxicon.2025.108540_bib42","article-title":"HIV-related cerebral toxoplasmosis revisited: current concepts and controversies of an old disease","volume":"18","author":"Vidal","year":"2019","journal-title":"J. Int. Assoc. Phys. AIDS Care"},{"key":"10.1016\/j.toxicon.2025.108540_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15020143","article-title":"The molecular composition of peptide toxins in the venom of spider Lycosa coelestis as revealed by cDNA library and transcriptomic sequencing","volume":"15","author":"Wu","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108540_bib44","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1074\/jbc.273.4.2059","article-title":"'Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis'","volume":"273","author":"Yan","year":"1998","journal-title":"J. Biol. Chem."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125003150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125003150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:42:08Z","timestamp":1772808128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010125003150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"alternative-id":["S0041010125003150"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108540","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Toxoplasma gondii studies of the venom peptide XYP4 from the Lycosa coelestis","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108540"}}